CLICK HERE FOR BRIUMVI® (ublituximab-xiiy) PRESCRIBING INFORMATION

JOIN US

Open Position

Title: Director, Internal Controls and SOX

Location: New York/New Jersey

If you are interested in the below position, please send your resume to [email protected] and REFERENCE THE POSITION TITLE within the subject line.

Organizational Overview

TG Therapeutics is a fully integrated, commercial stage, biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has received U.S. Food and Drug Administration (FDA) approval for BRIUMVI® (ublituximab-xiiy), for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval by the European Commission (EC) and the Medicines and Healthcare Products Regulatory Agency (MHRA) for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features in Europe and the United Kingdom, respectively. TG Therapeutics is headquartered in Morrisville, North Carolina. For more information, visit www.tgtherapeutics.com.

Role

This role will oversee the company’s internal controls including the company’s Sarbanes-Oxley (SOX) compliance program while ensuring compliance with accounting rules and best practices. This position provides support, and management of TG’s program for compliance with SOX Section 404, which requires all functions to document, test and assess internal controls over financial reporting. Reporting to the Chief Financial Officer, this role acts as the key point of contact for the company’s external auditors, the finance function and all critical process owners on all matters related to internal controls and SOX compliance, including evaluation and resolution of identified control deficiencies and control improvement initiatives. This position will conduct financial risk assessments and coordinate the scope of the annual SOX assessment process, evaluate the design and effectiveness of business processes and controls, serve as a technical resource on all SOX matters, including development, refinement, monitor remediation activities, and documentation of internal controls. .

Key Responsibilities

Oversee company-wide internal controls and SOX program.

Perform risk assessment, control design, flowchart development, and process design activities.

Continuously monitor control design and assess business changes to implement new processes and controls.

Oversee process walkthroughs and identification of design or other gaps in the control process.

Coordinate the testing of company wide internal controls and document control effectiveness.

Manages testing schedule and liaises with third-party resources, internal resources and external auditors.

Perform assessment over identified control deficiencies and propose and monitor remediation plans through final control deficiency remediation.

Manage reporting of SOX control deficiencies and remediation plans as part of quarterly reporting to the Audit Committee.

Evaluate and propose process improvements to improve efficiency and effectiveness of the Company’s SOX program and control environment including technology improvements.

Interact with senior management, including CFO, and audit committee as part of the reporting process.

Continually interface with senior leaders to maintain knowledge of the changes in business and emerging risks including controls related to the business and testing of those controls.

Coordinate internally and with external audit on the audit plan for testing and remediation of controls.

Conduct internal SOX training and educate control and process owners on best practices.

Field SOX inquiries from business partners and propose process and control changes as necessary.

Perform other duties as necessary.

Travel 10-15% to TG’s offices to attend meetings, etc., as required.

Professional Experience/Qualifications

High degree of technical proficiency including specific experience overseeing SOX controls


Strong project management, prioritization and communication skills required


Effective collaborator with an ability to act independently and as a part of a team.


Ability to identify process improvement opportunities and aptitude for continuous improvement and change


Proficiency in Microsoft Office tools (e.g., Excel, PowerPoint, and Word)


Minimum of 6 years in related work experience, Auditing, Controls, Accounting, or Finance experience. Part of the experience would have been obtained from employment with a major Public Accounting firm and/or as a member of an Internal Controls function of a U.S. public company.


Experience in biotechnology preferred but not required.

Education

• BS or BA in Accounting or Finance
• CPA or CIA Certification required

 

 

TG Therapeutics is an equal employment opportunity employer, and does not discriminate on the basis of race, color, religion, gender, sexual orientation, gender identity or expression, age, disability, national origin, ancestry, genetic information, military or veteran status, pregnancy or pregnancy-related condition or any other protected characteristic.